Stock Screener App

Gratuito -

Installare

39.19

2.56% -1.03

after-market

Dopo l'orario di chiusura: 39.19

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TEVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Teva Pharmaceutical Industries Ltd Adr Borsa (TEVA) Ultime notizie

Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history - Yahoo Finance UK

Teva Releases Q3 2026 Aide Memoire - GlobeNewswire Inc.

Teva stock hits 52-week high at $39.71 - Investing.com

TEVA Stock Price and Chart — TASE:TEVA - TradingView

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

TEVA Stock Quote Price and Forecast - CNN

Teva plans senior notes offering to refinance existing debt By Investing.com - Investing.com Canada

TEVA Stock Price, Quote & Chart - ChartMill

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers - TradingView

Teva announces commitment with Trump administration on Medicaid drug pricing By Investing.com - Investing.com South Africa

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy - Sahm

Teva Pharma Industries Ltd ADR (TEVA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Teva stock hits 52-week high at 37.84 USD By Investing.com - Investing.com Australia

Teva Pharmaceutical Industries (TEVA) Could Be 10% Undervalued After FDA Accepted Ecopipam NDA - sahmcapital.com

Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate - Sahm

Teva receives FDA priority review for Tourette drug - grafa.com

Teva Pharmaceutical’s stock is near its yearly high; is it still a buy? - Investing.com Nigeria

TEVA PHARMACEUTICAL INDUSTRIES LTD SEC Filing (Aug 17, 2026) - Stock Titan

Teva stock hits 52-week high at 37.35 USD By Investing.com - Investing.com Nigeria

Teva stock hits 52-week high at 37.35 USD - Investing.com

Moody’s upgrades Teva rating to investment grade on debt cuts By Investing.com - Investing.com Canada

Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open - Sahm

Teva (TEVA) Is Up 8.8% After Raising 2026 Guidance And Highlighting Innovative Drug Momentum - Sahm

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14 - Yahoo Finance

Teva Earnings: Innovation Engine Continues Firing and Supports Our Increased Moat Rating - Morningstar

July 2026's Top Stock Selections Estimated Below Intrinsic Value - Sahm

Teva Pharmaceutical Industries (TEVA) Raises Revenue Guidance, Is The 15% Undervaluation Still There? - Sahm

Earnings call transcript: Teva’s Q2 2026 revenue beats, shares rise premarket - Investing.com

Why Is Teva (NYSE:TEVA) Making NYSE Composite Headlines? - Kalkine Media

Daily Brief Health Care: Apnimed, Chugai Pharmaceutical, Equifax Inc, Royalty Pharma , Startline, Surgery Partners, Teva Pharmaceutical Sp Adr, Thermo Fisher Scientific Inc and more - Smartkarma

Teva Pharmaceutical Industries Limited Sponsored ADR Revenue Breakdown – BX:TEV - TradingView

Does Teva Pharmaceutical Industries (NYSE:TEVA) Still Look Undervalued After A 260% Run? - Sahm

What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders - Sahm

MINT,TEVA Volatility & Greeks - Finviz

Teva Pharmaceutical Industries (TEVA) Advances TEV 408, Is The Stock Still Cheap? - Sahm

Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap - Sahm

Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress - Sahm

HLN

$9.26

0.43%

TAK

$18.86

1.45%

ZTS

$71.05

1.11%

VTRS

$17.83

2.35%

UTHR

$475.45

0.69%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters